IL140364A0 - A mutant human hepatitis b viral strain and uses thereof - Google Patents

A mutant human hepatitis b viral strain and uses thereof

Info

Publication number
IL140364A0
IL140364A0 IL14036498A IL14036498A IL140364A0 IL 140364 A0 IL140364 A0 IL 140364A0 IL 14036498 A IL14036498 A IL 14036498A IL 14036498 A IL14036498 A IL 14036498A IL 140364 A0 IL140364 A0 IL 140364A0
Authority
IL
Israel
Prior art keywords
mutant human
human hepatitis
viral strain
viral
strain
Prior art date
Application number
IL14036498A
Other languages
English (en)
Original Assignee
Government Of The Republic Of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of The Republic Of Singapore filed Critical Government Of The Republic Of Singapore
Publication of IL140364A0 publication Critical patent/IL140364A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14036498A 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof IL140364A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG1998/000046 WO1999066048A1 (en) 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof

Publications (1)

Publication Number Publication Date
IL140364A0 true IL140364A0 (en) 2002-02-10

Family

ID=20429862

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14036498A IL140364A0 (en) 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof

Country Status (22)

Country Link
US (1) US6558675B1 (xx)
EP (1) EP1098981A1 (xx)
JP (1) JP2002518014A (xx)
KR (1) KR100498118B1 (xx)
CN (1) CN1322251A (xx)
AR (1) AR020093A1 (xx)
AU (1) AU756866B2 (xx)
BG (1) BG105066A (xx)
BR (1) BR9815913A (xx)
CA (1) CA2330935C (xx)
HU (1) HUP0103409A3 (xx)
IL (1) IL140364A0 (xx)
IS (1) IS5778A (xx)
MX (1) MXPA00012720A (xx)
MY (1) MY118955A (xx)
NO (1) NO20006456L (xx)
NZ (1) NZ508890A (xx)
PL (1) PL192129B1 (xx)
TR (1) TR200003777T2 (xx)
UA (1) UA73476C2 (xx)
WO (1) WO1999066048A1 (xx)
YU (1) YU80600A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200643171A (en) 2005-06-07 2006-12-16 Temasek Life Sciences Lab Ltd Porcine circovirus type 2 vaccines
US11497808B2 (en) 2019-09-30 2022-11-15 Gilead Sciences, Inc. HBV vaccines and methods treating HBV
CN113201051B (zh) * 2021-04-27 2022-08-02 复旦大学 一种乙肝病毒表面蛋白突变体及其在抗乙肝病毒中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401987D0 (en) 1994-02-02 1994-03-30 Imperial College Modified nucleic acid
EP0969863A4 (en) 1996-09-18 2001-11-07 Univ Texas DEFECTIVE VIRAL INTERFERENCE PARTICLES AND THEIR USE.

Also Published As

Publication number Publication date
BG105066A (en) 2001-09-28
WO1999066048A1 (en) 1999-12-23
CA2330935C (en) 2005-05-10
YU80600A (sh) 2005-06-10
KR100498118B1 (ko) 2005-07-01
HUP0103409A2 (hu) 2001-12-28
BR9815913A (pt) 2001-12-26
AU7795198A (en) 2000-01-05
NZ508890A (en) 2004-04-30
US6558675B1 (en) 2003-05-06
NO20006456L (no) 2001-02-16
CA2330935A1 (en) 1999-12-23
CN1322251A (zh) 2001-11-14
AU756866B2 (en) 2003-01-23
EP1098981A1 (en) 2001-05-16
IS5778A (is) 2000-12-19
PL345573A1 (en) 2001-12-17
PL192129B1 (pl) 2006-09-29
AR020093A1 (es) 2002-04-10
TR200003777T2 (tr) 2001-06-21
MY118955A (en) 2005-02-28
UA73476C2 (en) 2005-08-15
JP2002518014A (ja) 2002-06-25
MXPA00012720A (es) 2002-05-08
KR20010106129A (ko) 2001-11-29
HUP0103409A3 (en) 2003-10-28
NO20006456D0 (no) 2000-12-18

Similar Documents

Publication Publication Date Title
GB2353529B (en) Mutant herpes simplex viruses and uses thereof
HUP9801242A3 (en) Hepatitis b vaccine
HUP9901901A3 (en) Vaccines against hepatitis c
GB9415369D0 (en) Mutant virus
IL140363A0 (en) A vaccine-induced hepatitis b viral strain and uses thereof
AU3238995A (en) Hepatitis a virus receptor and methods of use
GB2359083B (en) Mutant herpes simplex viruses and uses thereof
HK1034202A1 (en) Combined vaccine against hepatitis a and hepatitisb
HUP0103409A3 (en) A mutant human hepatitis b viral strain and uses thereof
IL135822A0 (en) A novel gene and uses thereof
EP0910849A4 (en) CAPABLE FEEDBACK HEADPHONES AND COMPUTER AUDIOMETER PROVIDED WITH SUCH HEADPHONES
GB2336137B (en) A frame member and a frame assembly
AU1133995A (en) Creep resistant iron-chromium-aluminum alloy and article thereof
IL136514A0 (en) Beta-lipotropin and uses thereof
SI1073462T1 (sl) Kombinirano cepivo proti hepatitisu A in hepatitisu B
GB2357688B (en) Rein grip and a rein including the rein grip
AU6006600A (en) A baby gym and a clamp unit
ZA95105B (en) Red-dot HIV 1 and 2
TW341209U (en) A baby walking chair and carriage
SI0810877T1 (en) Hepatitis b vaccine
TW343649U (en) A disposable recipient
GB9301517D0 (en) Disposable hand shovel and bag
AU128122S (en) A child's chair
GB9405876D0 (en) Modified virus and its use as a vector
GB9413517D0 (en) Viral vaccines